Kamada Ltd.
(TEL Aviv Stock Exchange : KMDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -3.84%326.540.0%$4164.11m
NVAXNovavax, Inc. -3.05%134.5679.4%$783.60m
BNTXBioNTech SE -2.80%278.340.0%$777.03m
AMGNAmgen, Inc. 0.12%209.241.4%$532.78m
REGNRegeneron Pharmaceuticals, Inc. 0.53%572.362.7%$454.63m
SNSSSunesis Pharmaceuticals, Inc. -0.33%6.090.7%$425.71m
CCXIChemoCentryx, Inc. -1.26%34.572.9%$397.56m
GILDGilead Sciences, Inc. 0.37%67.241.0%$393.07m
ILMNIllumina, Inc. -0.59%409.153.3%$356.80m
XLRNAcceleron Pharma, Inc. 0.12%173.955.3%$346.86m
VRTXVertex Pharmaceuticals, Inc. -1.91%183.521.9%$275.34m
BIIBBiogen, Inc. -2.00%264.801.7%$255.53m
OCGNOcugen, Inc. -1.66%8.320.0%$187.94m
XENEXenon Pharmaceuticals, Inc. 0.75%30.860.4%$166.06m
CRSPCRISPR Therapeutics AG -1.55%95.560.6%$159.15m

Company Profile

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.